# Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

> **NCT01247246** · PHASE2 · UNKNOWN · sponsor: **SciClone Pharmaceuticals** · enrollment: 160 (estimated)

## Conditions studied

- Oral Mucositis

## Interventions

- **DRUG:** SCV-07
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01247246
- **Lead sponsor:** SciClone Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2014-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01247246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01247246, "Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01247246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*